SMO and Ewing sarcoma: To corroborate that CSNK1D inhibition is a potent strategy to block GLI activation in SMOi-resistant settings, we performed chemical inhibition of CSNK1D in A673 and MHH-ES-1 Ewing sarcoma cells both showing SMO-independent GLI1 expression.